Egle Therapeutics’ €40 Million Series A Funding Round

McDermott Will & Emery advised Egle Therapeutics on the deal. Gide advised the pool of investors, while Morgan, Lewis & Bockius advised Takeda Ventures.Egle Therapeutics, which…

This content is for Standard 1 Year members only.
Login Join Now

Riddell’s Partnership with BC Partners Credit

ZOOZ Power’s Business Combination with Keyarch Acquisition Corporation

Boeing’s Securities Fraud

ICC Inversiones’ Acquisition of 20,1% Stake in Grupo Patio SpA

Transocean’s $1.8 Billion Senior Notes Offering and Cash Tender Offers

GDM’s Acquisition of KWS’s Corn and Sorghum Business in South America

Omron Healthcare’s Acquisition of Luscii Healthtech

Novamedia’s Acquisition of Holding GDL

Gridbeyond Limited’s Series C Investment Round

KOKO Networks Limited’s Financing Round

India Vehicle Finance’s Notes Offering

Al-Arafa’s Demerger into Concrete Fashion Group and GTEX

SC Ventures’ $100 Million Joint Venture With SBI Holdings

GreenCorp’s Acquisition of Emad Bakeries

MedOne’s Agreement with Shikun and Binui Energy

Weihai City’s Bonds Offering

ScotPac’s Term Securitisation

American Industrial Partners’ Acquisition of Boart Longyear

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Hefesto Asesores continues to consolidate its position in the International Private Equity and Venture Capital market, with the formation of Hefesto Global

Paul Hastings Adds Premier Private Equity Buyout Team

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Paul Hastings Adds Premier Private Equity Buyout Team

BCLP Appoints Trevor Varnes as Chief Financial Officer

Egle Therapeutics’ €40 Million Series A Funding Round

Author: Naoual Sadouqi